Questionable Testing Common After Ovarian Cancer Therapy Questionable Testing Common After Ovarian Cancer Therapy
Despite evidence that cancer antigen 125 (CA-125) tests and CT scans for surveillance in ovarian cancer patients are not beneficial after treatment, the practice continues, according to a multicenter study.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | CT Scan | Health | Hematology | Ovarian Cancer | Ovaries | Pathology | PET Scan | Study